Latest filing published 22 Jun 2026 for Maxcyte, INC.. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William W. Brooke discloses dealings in Maxcyte, Inc. to SEC (Form 4). In total, 4 filings cover trades dated from 11 June 2024 to 17 June 2026.
On the market, this insider has only ever bought: 1 purchase, €55k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants.
The record was last updated on 22 June 2026 with a share grant in Maxcyte, Inc. The last purchase on record was published on 13 August 2025, which is 431 days ago. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations